VAERS reports by lot

Pfizer COVID-19 lot EL1686: VAERS reports

20 VAERS reports list lot EL1686 as a Pfizer COVID-19 vaccine, received between 2021-01-06 and 2021-12-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
1
With a death outcome
5
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2545%
Neurological611%
Gastrointestinal611%
Dermatological (non-injection-site)611%
Cardiac / Cardiovascular59%
Respiratory47%
Injection-site / Local reaction47%

Where reports came from

U.S. state of the reporter, where given (top 11).

Texas4
California4
Missouri2
Ohio2
Utah2
Indiana1
Colorado1
Maryland1
Massachusetts1
Delaware1
Hawaii1

Reports by month received

2021-0110
2021-024
2021-034
2021-071
2021-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.